CXCL2, a new critical factor and therapeutic target for cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Previous studies have shown that inflammatory chemokines are involved in the physiological functions of cytoskeletal reorganization, cell migration, adhesion and immune responses. However, in the past decade, there have been st...
Main Authors: | Lin-Ya Guo, Fang Yang, Li-Jun Peng, Yan-Bing Li, Ai-Ping Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-07-01
|
Series: | Clinical and Experimental Hypertension |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10641963.2019.1693585 |
Similar Items
-
MIF and CXCL12 in cardiovascular diseases: functional differences and similarities
by: Emiel eVan Der Vorst, et al.
Published: (2015-07-01) -
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
by: Xin Yu, et al.
Published: (2022-11-01) -
The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023-01-01) -
Macrophage phenotype modulation by CXCL4 in vascular disease
by: Christian Albert Gleissner
Published: (2012-01-01) -
Circulating CXCL16 in Diabetic Kidney Disease
by: Usama Elewa, et al.
Published: (2016-09-01)